10-year

10-Year Anniversary Promotion (20% off)

Join GuruFocus Premium Membership Now for Only $279/Year

Once a decade discount

Save up to $500 on Global Membership.

Don't Miss It !

Free 7-day Trial
All Articles and Columns »

Weekly Top Insider Sells: INTU, NEE, REGN, CAM

September 11, 2011 | About:
gurugk

gurugk

0 followers
According to GuruFocus Insider Data, these are the largest insider sells during the past week.

Intuit Inc. (INTU): Director David H. Batchelder sold 3,037,716 Shares

Director of Intuit Inc. (INTU) David H. Batchelder sold 3,037,716 shares on 09/08/2011 at an average price of $46.24.

Intuit's mission is to revolutionize how people manage their financial activities. Intuit Inc. has a market cap of $14.06 billion; its shares were traded at around $46.24 with a P/E ratio of 21.1 and P/S ratio of 3.5. Intuit Inc. had an annual average earnings growth of 18.2% over the past 10 years. GuruFocus rated Intuit Inc.the business predictability rank of 4-star.

Intuit Inc. announced financial results for its fourth quarter and full fiscal year 2011, which ended July 31, and provided initial guidance for fiscal year 2012. The company also announced it will pay shareholders a cash dividend for the first time in its history. Increased revenue by 11%, to $3.85 billion. Increased GAAP diluted earnings per share by 13 percent and non-GAAP diluted EPS by 19 percent. Delivered another strong season for Consumer Tax, growing units 12 percent and revenue 13%. Achieved double-digit revenue growth in all three Small Business segments, driven by customer growth and improving revenue per customer. Generated growth through connected services with QuickBooks Online subscribers up 41% and TurboTax Online subscribers up 20%. Grew end users to more than 35 million on hosted products and services, accelerated by the adoption of mobile solutions. Repurchased stock totaling nearly $1.4 billion for the year, including $250 million in the fourth quarter.

Director David H. Batchelder sold 227,827 shares of INTU stock on 06/21/2011 at the average price of $49.55. David H. Batchelder owns at least 11,131,677 shares after this. The price of the stock has decreased by 6.68% since.

NextEra Energy Inc. (NEE): Chairman and CEO Lewis Hay III sold 150,000 Shares

Chairman and CEO of NextEra Energy Inc. (NEE) Lewis Hay III sold 150,000 shares on 09/01/2011 at an average price of $53.6.

NextEra Energy Inc., formerly known as FPL Group Inc., has a market cap of $22.64 billion; its shares were traded at around $53.6 with a P/E ratio of 12.3 and P/S ratio of 1.5. The dividend yield of NextEra Energy Inc stocks is 4.1%. NextEra Energy Inc. had an annual average earnings growth of 5.7% over the past 10 years. GuruFocus rated NextEra Energy Inc. the business predictability rank of 3-star.

On July 27, NextEra Energy Inc. reported second quarter 2011 net income on a GAAP basis of $580 million, or $1.38 per share, compared with $417 million, or $1.01 per share, in the second quarter of 2010. On an adjusted basis, NextEra Energy's earnings were $500 million, or $1.18 per share, compared with $457 million, or $1.11 per share, in the second quarter of 2010. Adjusted earnings exclude the mark-to-market effects of non-qualifying hedges and other than temporary impairments (OTTI) on certain investments, both of which relate to the business of NextEra Energy Resources, LLC and its affiliated entities ("NextEra Energy Resources").

Chairman of Sub Lewis Hay III sold 12,599 shares of NEE stock on 04/28/2011 at the average price of 57. Lewis Hay Iii owns at least 668,799 shares after this. The price of the stock has decreased by 5.96% since.

Regeneron Pharmaceuticals Inc. (REGN): Chairman of the Board P. Roy Vagelos sold 92,455 Shares

Chairman of the Board of Regeneron Pharmaceuticals Inc. (REGN) P. Roy Vagelos sold 92,455 shares on 09/02/2011 at an average price of $65.621.

Regeneron Pharmaceuticals Inc. is a biopharmaceutical company that discovers, develops, and intends to commercialize therapeutic drugs for the treatment of serious medical conditions. Regeneron Pharmaceuticals Inc. has a market cap of $6.01 billion; its shares were traded at around $65.621 with and P/S ratio of 13.1.

On July 28, 2011 Regeneron Pharmaceuticals Inc. announced financial results for the second quarter of 2011 and provided an update on development programs and upcoming milestones. The company's total operating expenses increased to $168.1 million in the second quarter of 2011 from $139.6 million in the same quarter of 2010, and to $321.3 million for the first six months of 2011 from $272.0 million for the same period of 2010. Research and development (R&D) expenses in the second quarter of 2011 rose to $143.1 million from $124.5 million in the same quarter of 2010 and to $272.5 million in the first six months of 2011 from $242.0 million for the same period of 2010. These increases in R&D expenses were primarily due to the Company's expanding R&D headcount and activities, principally in connection with the Sanofi antibody collaboration. In addition, selling, general, and administrative (SG&A) expenses in the second quarter of 2011 rose to $24.6 million from $14.7 million in the same quarter of 2010 and to $48.0 million in the first six months of 2011 from $28.9 million for the same period of 2010. These increases in SG&A expenses in the first half of 2011 were primarily due to higher headcount, higher recruiting and compensation costs, and higher commercialization-related costs in connection with preparing to launch EYLEA™ for the treatment of wet AMD.

The company had a net loss of $62.5 million, or $0.69 per share (basic and diluted), for the second quarter of 2011 compared with a net loss of $25.5 million, or $0.31 per share (basic and diluted), for the second quarter of 2010. The company had a net loss of $106.0 million, or $1.18 per share (basic and diluted), for the first six months of 2011 compared with a net loss of $56.0 million, or $0.69 per share (basic and diluted), for the same period of 2010.

At June 30, 2011, cash and marketable securities totaled $569.1 million (including $8.2 million of restricted cash and marketable securities) compared with $626.9 million (including $7.5 million of restricted cash and marketable securities) at Dec. 31, 2010.

Chairman of the Board P. Roy Vagelos sold 92,455 shares of REGN stock on 09/02/2011 at the average price of $61.11. P. Roy Vagelos owns at least 572,839 shares after this. The price of the stock has increased by 7.38% since.

Cameron International Corp. (CAM): Director Sheldon R. Erikson sold 100,000 Shares

Director of Cameron International Corp. (CAM) Sheldon R. Erikson sold 100,000 shares on 09/01/2011 at an average price of $48.28.

Cooper Cameron Corporation's is a provider of flow equipment products, systems and services to worldwide oil, gas and process industries. Cameron International Corp. has a market cap of $11.83 billion; its shares were traded at around $48.28 with a P/E ratio of 19.8 and P/S ratio of 1.9. Cameron International Corp. had an annual average earnings growth of 22.3% over the past 10 years. GuruFocus rated Cameron International Corp. the business predictability rank of 3.5-star.

On July 28, 2011 Cameron reported net income of $148.0 million, or $0.59 per diluted share, for the quarter ended June 30, 2011, compared with net income of $129.2 million, or $0.52 per diluted share, for the second quarter of 2010. The second quarter 2011 results include pre-tax charges of $20.1 million, or $0.07 per share, primarily related to litigation and restructuring costs. The second quarter 2010 results included pre-tax charges of $18.4 million, or $0.06 per diluted share, related to the continued integration of the NATCO Group Inc. acquisition, as well as litigation and severance costs. Year-over-year revenues increase in every segment. Revenues were $1.74 billion for the quarter, up 19.9 percent from $1.45 billion a year ago, and income before income taxes was $187.4 million.

Director Sheldon R. Erikson sold 50,000 shares of CAM stock on 05/09/2011 at the average price of 49.51. Sheldon R. Erikson owns at least 2,069,393 shares after this. The price of the stock has decreased by 2.48% since.

For the complete list of stocks that bought/sold by their company executives, go to: Insider Buys.
  • CEO Buys, CFO Buys: Stocks that are bought by their CEO/CFOs.
  • Insider Cluster Buys: Stocks that multiple company officers and directors have bought.
  • Double Buys:: Companies that both Gurus and Insiders are buying
  • Triple Buys: Companies that both Gurus and Insiders are buying, and Company is buying back.

» Take a Free Trial of Premium Membership


Rating: 3.0/5 (3 votes)

Comments

Please leave your comment:


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK